Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer

NCT03076567 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03076567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03076567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
March 9, 2017
Completion date
February 21, 2020
Enrollment
440 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, stomach cancer